New EU Restrictions On Biogen’s MS Drug Zinbryta Are ‘Damaging’, Analyst Warns

 
• By Neena Brizmohun
  
Multiple Sclerosis
The EMA is placing further restrictions on the use of Biogen's MS drug

More from Drug Safety

More from Pink Sheet